Cargando…
The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
BACKGROUND: Coronavirus disease 2019 (COVID-19) has infected people in many countries worldwide. Discovering an effective treatment for this disease, particularly in severe cases, has become the subject of intense scientific investigation. Therefore, the objective of this study was to evaluate the e...
Autores principales: | Gharebaghi, Naser, Nejadrahim, Rahim, Mousavi, Seyed Jalil, Sadat-Ebrahimi, Seyyed-Reza, Hajizadeh, Reza |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7576972/ https://www.ncbi.nlm.nih.gov/pubmed/33087047 http://dx.doi.org/10.1186/s12879-020-05507-4 |
Ejemplares similares
-
Correction to: The use of intravenous immunoglobulin gamma for the treatment of severe coronavirus disease 2019: a randomized placebo-controlled double-blind clinical trial
por: Gharebaghi, Naser, et al.
Publicado: (2020) -
Severe acute respiratory syndrome coronavirus-2- or pregnancy-related cardiomyopathy, a differential to be considered in the current pandemic: a case report
por: Nejadrahim, Rahim, et al.
Publicado: (2021) -
Role of MicroRNAs in Diagnosis, Prognosis, and Treatment of Acute Heart Failure: Ambassadors from Intracellular Zone
por: Sadat-Ebrahimi, Seyyed-Reza, et al.
Publicado: (2020) -
The association between T wave inversion in leads with ST-elevation and patency of the infarct-related artery
por: Ranjbar, Abdolmohammad, et al.
Publicado: (2021) -
A Preliminary Randomized Double Blind Placebo-Controlled Trial of Intravenous Immunoglobulin for Japanese Encephalitis in Nepal
por: Rayamajhi, Ajit, et al.
Publicado: (2015)